Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature.
Estudio retrospectivo
Glomerulonefritis membranosa
Lupus eritematoso sistémico
Membranous glomerulonephritis
Retrospective review
Systemic lupus erythematosus
Journal
Reumatologia clinica
ISSN: 2173-5743
Titre abrégé: Reumatol Clin (Engl Ed)
Pays: Spain
ID NLM: 101717526
Informations de publication
Date de publication:
Historique:
received:
01
02
2017
revised:
22
03
2017
accepted:
13
04
2017
pubmed:
23
5
2017
medline:
15
6
2019
entrez:
23
5
2017
Statut:
ppublish
Résumé
The course and long-term outcome of pure membranous lupus nephritis (MLN) are little understood. The aims of this study are to evaluate the clinical features, course, outcome and prognostic indicators in pure MLN and to determine the impact of ethnicity and the type of health insurance on the course and prognosis of pure MLN. We conducted a retrospective review of medical records of 150 patients with pure MLN from Spain and the USA. Mean age was 34.2±12.5 and 80% were women. Sixty-eight percent of patients had nephrotic syndrome at diagnosis. The average serum creatinine was 0.98±0.78mg/dl. Six percent of patients died and 5.3% developed end-stage renal disease (ESRD). ESRD was predicted by male sex, hypertension, dyslipidemia, high basal 24h-proteinuria, high basal serum creatinine and a low basal creatinine clearance. Age, cardiac insufficiency, peripheral artheriopathy, hemodialysis and not having received mycophenolate mofetil or antimalarials for MLN predicted death. Pure MLN frequently presents with nephrotic syndrome, high proteinuria and normal serum creatinine. Its prognosis is favourable in maintaining renal function although proteinuria usually persists over time. Baseline cardiovascular disease and not having a health insurance are related with poor prognosis.
Identifiants
pubmed: 28528869
pii: S1699-258X(17)30096-7
doi: 10.1016/j.reuma.2017.04.005
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
spa
Sous-ensembles de citation
IM
Pagination
34-42Informations de copyright
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.